Last updated: July 18, 2023
Sponsor: Alcon Research
Overall Status: Completed
Phase
N/A
Condition
Sjogren's Syndrome
Dermatomyositis (Connective Tissue Disease)
Eye Disorders/infections
Treatment
Lotrafilcon A contact lenses
Clinical Study ID
NCT05891106
CLD265-P002
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Key Inclusion Criteria:
- Diagnosis of a corneal condition with pain for which AONDA Soft Contact Lens as atherapeutic contact lens was placed on one or both eye(s) at Baseline.
- Baseline and Follow-up (up to 1 year from Baseline) charts available.
- Other protocol-defined inclusion criteria may apply.
Exclusion
Key Exclusion Criteria:
- Had a condition (pathological, behavioral, and/or situational) that contraindicatedtherapeutic contact lens wear or confounds study results during the data collectionperiod, as determined or known by the Investigator.
- Used systemic or ocular medication that would confound study results during the datacollection period, as determined or known by the Investigator.
- Other protocol-defined exclusion criteria may apply.
Study Design
Total Participants: 55
Treatment Group(s): 1
Primary Treatment: Lotrafilcon A contact lenses
Phase:
Study Start date:
June 28, 2023
Estimated Completion Date:
July 10, 2023
Study Description
Connect with a study center
Vision Health Institute
Orlando, Florida 32803
United StatesSite Not Available
Franklin Park Eye Center PC
Franklin Park, Illinois 60131
United StatesSite Not Available
Optometry Group, PLLC
Memphis, Tennessee 38111
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.